FRA
HCA icon

Frank Rimerman Advisors’s HCA Healthcare HCA Stock Holding History

Frank Rimerman Advisors’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.58M Sell
6,617
-228
-3% -$96.4K 0.15% 115
2026
Q1 		$3.24M Buy
6,845
+44
+0.6% +$22.1K 0.21% 79
2025
Q4 		$3.18M Buy
6,801
+39
+0.6% +$18.1K 0.2% 86
2025
Q3 		$2.88M Buy
6,762
+56
+0.8% +$21.7K 0.18% 87
2025
Q2 		$2.57M Sell
6,706
-193
-3% -$69.5K 0.17% 97
2025
Q1 		$2.38M Buy
6,899
+267
+4% +$85.9K 0.19% 90
2024
Q4 		$1.99M Sell
6,632
-133
-2% -$46.5K 0.14% 111
2024
Q3 		$2.75M Sell
6,765
-8
-0.1% -$2.93K 0.2% 85
2024
Q2 		$2.18M Buy
6,773
+6,760
+52,000% +$2.2M 0.15% 110
2024
Q1 		$4.34K Hold
13
– – ﹤0.01% 215
2023
Q4 		$3.52K Buy
+13
New +$3.21K ﹤0.01% 224
2023
Q3 		– Sell
-711
Closed -$216K – 107
2023
Q2 		$216K Sell
711
-122
-15% -$33.9K 0.05% 101
2023
Q1 		$220K Sell
833
-5
-0.6% -$1.27K 0.06% 98
2022
Q4 		$201K Buy
+838
New +$188K 0.06% 92

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Frank Rimerman Advisors's HCA Position: Q2 2026 in Review

Frank Rimerman Advisors reduced its HCA Healthcare (HCA) stake by 3.3% in Q2 2026, selling an estimated $96.4K and leaving 6,617 shares worth $2.58M. The position accounts for 0.15% of the portfolio, ranked #115.

Frank Rimerman Advisors first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.24M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Frank Rimerman Advisors held 6,617 shares of HCA Healthcare worth $2.58M as of Q2 2026.
  • Frank Rimerman Advisors sold 228 HCA Healthcare shares in Q2 2026, an estimated $96.4K.
  • HCA Healthcare made up 0.15% of Frank Rimerman Advisors's portfolio in Q2 2026, its #115 holding.
  • Frank Rimerman Advisors first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • Frank Rimerman Advisors's HCA Healthcare position peaked at $3.24M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.